Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 53.52B | 53.92B | 52.77B | 48.60B | 49.06B | 46.25B |
Gross Profit | 8.72B | 9.35B | 9.71B | 6.58B | 8.81B | 5.57B |
EBITDA | 5.97B | 7.27B | 5.86B | 4.77B | 7.25B | 3.41B |
Net Income | 2.84B | 2.96B | 1.77B | 788.00M | 2.84B | -1.31B |
Balance Sheet | ||||||
Total Assets | 44.55B | 44.89B | 46.36B | 43.06B | 42.94B | 44.35B |
Cash, Cash Equivalents and Short-Term Investments | 6.14B | 7.98B | 5.20B | 3.71B | 2.98B | 2.83B |
Total Debt | 918.00M | 580.35M | 2.39B | 5.15B | 7.02B | 10.62B |
Total Liabilities | 17.89B | 18.25B | 21.70B | 22.51B | 24.24B | 28.33B |
Stockholders Equity | 26.65B | 26.64B | 24.66B | 20.55B | 18.70B | 16.02B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 4.99B | 4.34B | 2.75B | 3.20B | -911.96M |
Operating Cash Flow | 0.00 | 7.18B | 6.56B | 5.24B | 5.44B | 2.95B |
Investing Cash Flow | 0.00 | -2.29B | -2.11B | -2.45B | -1.63B | -3.81B |
Financing Cash Flow | 0.00 | -2.10B | -3.03B | -2.10B | -3.83B | 529.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥10.66B | 16.89 | 3.17% | 3.98% | 4.62% | ||
75 Outperform | ¥9.29B | 3.15 | 2.68% | 2.17% | 66.19% | ||
73 Outperform | ¥8.63B | 6.93 | 3.50% | 8.63% | 9.65% | ||
70 Outperform | ¥8.68B | 6.09 | 7.18% | 0.69% | 7.21% | ||
62 Neutral | $16.65B | 11.16 | -7.38% | 3.11% | 1.59% | -23.30% | |
58 Neutral | ¥15.51B | 246.13 | 4.21% | 2.22% | -90.98% | ||
56 Neutral | ¥8.26B | ― | 2.76% | -3.96% | -462.50% |